What is the NVCR stock price prediction for next 2 weeks?

According to our price prediction algorithm,NovoCure Limited (NVCR) price will be around $13.82 in the next 2 weeks. This means it will increase by 3.9300751879699143 from the last closing price. This prediction may vary from other time period filters for NVCR stock.

What can be the highest Possible price of NVCR stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, NVCR can achieve the highest price of $14.98 which is 12.621856161915455 higher than last closing price. This prediction may vary from other time period filters for NVCR stock.

What can be the lowest Possible price of NVCR stock in next 2 weeks?

As per the forecast and algorithmic analysis, NVCR stock price can be as low as $12.67 which is -4.767725076180891 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for NVCR stock.

Will NVCR stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that NVCR stock will gain3.9300751879699143 in the next 2 weeks. This prediction may vary from other time period filters for NVCR stock.

What is NVCR stock last closing price?

Last closing price of NVCR stock was $13.30.

What is NVCR stock price prediction?

NVCR stock price prediction means predicting the future closing prices of NVCR stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of NVCR stock in a certain time period.

How we predict NVCR stock future prices?

If you are searching for NVCR stock forecast, analysis or price prediction, then you might be wondering what NovoCure Limited (NVCR) will do in the future. Our NVCR price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This NVCR price prediction will likely answer most of your questions.

How frequent we update NVCR stock predictions?

We are updating the forecasts for the NVCR stock on daily basis.

Is using ML forecasting for NVCR stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for NVCR stock same for all the time periods?

No, the prediction for NVCR stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

NovoCure Limited Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$13.3016.67%Since 2 Weeks

Predicted Price$13.823.93%For 2 Weeks

Upper Predicted Price$14.9812.62%For 2 Weeks

Lower Predicted Price$12.67-4.77%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of NVCR will rise by +3.93% over the next 2 Weeks and hit $13.82 by Tuesday, March 17, 2026. In that time frame, NVCR's share price is expected to range between $12.67 and $14.98.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Mar 17, 2026	12.67	13.82	14.98
Mar 16, 2026	12.66	13.82	15.04
Mar 13, 2026	12.83	13.96	15.06
Mar 12, 2026	13.08	14.24	15.46
Mar 11, 2026	13.05	14.20	15.32
Mar 10, 2026	12.48	13.62	14.80
Mar 9, 2026	12.47	13.62	14.73
Mar 6, 2026	12.60	13.75	14.95
Mar 5, 2026	12.92	14.03	15.13
Mar 4, 2026	12.89	13.99	15.12

NVCR shares rose +0.90% in Wednesday, March 4, 2026's trading session, rising from a previous close of $13.30 to move at $13.42. The stock demonstrated notable intraday movement (see NVCR's key stats for a full breakdown), fluctuating between $12.79 and $13.51, a +5.63% trading range. While recent weeks have seen some volatility, NVCR has managed to secure a +17.72% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 1.92M shares changing hands, 148.46K more than the previous session. This amounted to $25.76M in total market activity.

Will NVCR Continue Its Upward Trend?

According to analyst ratings and projections for NVCR, NovoCure Limited shares are anticipated to increase by +10.41%, potentially reaching $14.98 per share by March 17, 2026. Short-term technical indicators currently suggest a neutral sentiment for NVCR. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 11 positive trading days within the past 30 sessions. Based on the NVCR stock forecast, now is a good time to buy NVCR stock because its current trading price is -2.91% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on NVCR covering social and institutional perspectives.

NVCR Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into NVCR's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 54.67% to 58.79%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 51.36%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 49.29%, maintains a neutral outlook for the long term. Insights into NVCR's shareholder base show how institutional investors are positioning themselves during these momentum shifts

NovoCure Short-Term Forecasts

NVCR Forecast For Next 5 Days

Our algorithm anticipates NovoCure (NVCR) stock could hit $12.54 by Mar 11, 2026. This represents a -6.57% fall from today's price, following a -8.22% change over the past five days.

NVCR Forecast For Next 30 Days

Based on analysis of market trends, the outlook for NovoCure Limited (NVCR) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $13.24, which would mean a -1.34% decrease from the current price of $13.42. Projections for this period range from a high of $15.82 to a low of $10.87.

NVCR Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for NovoCure's price over the next three months point to a rise. NVCR stock is expected to peak at $20.21 on May 21, 2026 after potentially dipping to $10.71 on Apr 29, 2026. On average, NVCR is likely to trade around $14.86 in the coming 90 days.

NovoCure Stock Forecast 2025

Based on our predictive models, NovoCure (NVCR) is expected to trade between $5.37 and $20.21 throughout 2026. This would result in an average price of $12.56, potentially offering investors a -6.41% return from current levels.

NovoCure Limited Monthly Forecast 2026–2027

March 2026

According to our latest forecast models, NovoCure Limited (NVCR) is positioned to show a strong performance in March 2026. The price is predicted to move between $12.78 and $16.77, settling at an average of $14.73. This could translate to a +9.76% gain.

April 2026

Based on current market signals, NovoCure Limited is projected to trend april 2026. We forecast a trading range from $10.71 to $15.18, with a likely average price of $12.96. Investors could expect a potential return of -3.43%.

May 2026

Our predictive algorithms indicate NovoCure Limited stock may see a shift in May 2026. The expected range spans $11.10–$20.21, with an average target of $16.49. This represents a positive outlook and a possible gain of +22.88%.

June 2026

Analyzing established trends, NovoCure Limited looks set to move in June 2026. Projections place the stock between $11.29 and $19.30, averaging around $14.26. This suggests a +6.26% gain from current levels.

July 2026

Market indicators suggest NovoCure Limited could experience notable changes during July 2026. Prices could fluctuate within $10.74 to $15.11, with a midpoint forecast of $13.07. The stock might deliver a -2.61% loss.

August 2026

Forecasting for August 2026, models estimate that NovoCure Limited may undergo key fluctuations. If trends hold, the stock might trade between $9.52 and $15.85, averaging $13.53. This signals a positive trajectory with potential returns around +0.82%.

September 2026

According to our latest forecast models, NovoCure Limited (NVCR) is positioned to show a strong performance in September 2026. The price is predicted to move between $6.22 and $12.99, settling at an average of $10.27. This could translate to a -23.47% loss.

October 2026

Based on current market signals, NovoCure Limited is projected to trend october 2026. We forecast a trading range from $5.80 to $11.56, with a likely average price of $9.51. Investors could expect a potential return of -29.14%.

November 2026

Our predictive algorithms indicate NovoCure Limited stock may see a shift in November 2026. The expected range spans $5.78–$12.52, with an average target of $9.89. This represents a cautious outlook and a possible loss of -26.30%.

December 2026

Analyzing established trends, NovoCure Limited looks set to move in December 2026. Projections place the stock between $5.37 and $12.78, averaging around $11.23. This suggests a -16.32% loss from current levels.

January 2027

Market indicators suggest NovoCure Limited could experience notable changes during January 2027. Prices could fluctuate within $4.68 to $15.06, with a midpoint forecast of $13.66. The stock might deliver a +1.79% gain.

February 2027

Forecasting for February 2027, models estimate that NovoCure Limited may undergo key fluctuations. If trends hold, the stock might trade between $2.74 and $12.73, averaging $11.52. This signals a cautious trajectory with potential returns around -14.16%.

March 2027

According to our latest forecast models, NovoCure Limited (NVCR) is positioned to show a strong performance in March 2027. The price is predicted to move between $2.27 and $10.15, settling at an average of $10.09. This could translate to a -24.81% loss.

NVCR's history of dividends and stock splits also plays a role in long-term investor confidence.